Orange Book product · Generic (ANDA)
DOXERCALCIFEROL
DOXERCALCIFEROL
At a glance
Feb 04, 2014
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 04, 2014
12 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
DOXERCALCIFEROL
Strength
4MCG/2ML (2MCG/ML)
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 200926
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DOXERCALCIFEROL
- 2018DOXERCALCIFEROLBrand (NDA)
NDA 208614 · HOSPIRA
- 2004HECTOROLBrand (NDA)
NDA 020862 · SANOFI
- 2000HECTOROLBrand (NDA)
NDA 021027 · SANOFI
- 2023DOXERCALCIFEROLGeneric (ANDA)
ANDA 215810 · ALEMBIC
- 2022DOXERCALCIFEROLGeneric (ANDA)
ANDA 213717 · EUGIA PHARMA
- 2020DOXERCALCIFEROLGeneric (ANDA)
ANDA 205360 · AVET
- 2020DOXERCALCIFEROLGeneric (ANDA)
ANDA 211670 · MEITHEAL
- 2019DOXERCALCIFEROLGeneric (ANDA)
ANDA 203875 · SUN PHARM
- 2019DOXERCALCIFEROLGeneric (ANDA)
ANDA 210452 · GLAND
- 2018DOXERCALCIFEROLGeneric (ANDA)
ANDA 210801 · LUPIN
- 2017DOXERCALCIFEROLGeneric (ANDA)
ANDA 208974 · AMNEAL
- 2017DOXERCALCIFEROLGeneric (ANDA)
ANDA 208975 · AMNEAL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
